logo
logo

Adc Therapeutics Announces $175 Million Senior Secured Term Loan From Owl Rock And Oaktree And Settlement Of Existing Senior Secured Convertible Notes

Aug 15, 2022•about 3 years ago

Amount Raised

$175 Million

LausanneTherapeuticsBiotechnologyHealth Care

Description

ADC Therapeutics SA (NYSE: ADCT) today announced that it has completed a series of strategic transactions in which it:

Company Information

Company

ADC Therapeutics

Location

Lausanne, Vaud, Switzerland

About

ADC Therapeutics (NYSE: ADCT) is a commercial-stage global leader and pioneer in the field of antibody drug conjugates (ADCs). The Company is advancing its proprietary ADC technology to transform the treatment paradigm for patients with hematologic malignancies and solid tumors.

Related People

0 contacts

No contacts found in Executives department

Try selecting a different department above

Funding Insights

Based on industry data
Tech investment trends
83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech